From a cancer drug fund to value based pricing of drugs: Such pricing may be hard to implement and may not add value
Autor: | Duerden, Martin |
---|---|
Zdroj: | BMJ: British Medical Journal, 2010 Aug . 341(7770), 412-413. |
Databáze: | JSTOR Journals |
Externí odkaz: |